Masif Kan Transfüzyonu
Özet
Masif kan transfüzyonu (MKT), genellikle 24 saat içinde 10 ünite veya daha kısa sürelerde belirli hacimlerde eritrosit süspansiyonu verilmesi olarak tanımlanan hayat kurtarıcı bir müdahaledir. Temel endikasyonu akut kan kaybına bağlı hemodinamik instabilite olup; travma, aort rüptürü ve cerrahi komplikasyonlar gibi durumlarda kritik öneme sahiptir. Tanı koymada ABC skoru gibi yöntemler kullanılarak hastanın MKT ihtiyacı belirlenir. MKT uygulamasında, koagülopatiyi önlemek için eritrosit, plazma ve trombositlerin belirli oranlarda (genellikle 1:1:1) verilmesi önerilir. Uygulama sırasında yüksek akış hızını sağlamak için kısa ve geniş çaplı kateterlerin kullanımı ile kanın vücut sıcaklığına ısıtılması esastır. Süreç, ortalama arter basıncı 60-65 mmHg ve hemoglobin 7-9 g/dL gibi hedef değerlere ulaşılana kadar devam ettirilir. Masif transfüzyon; koagülopati, sitrat toksisitesine bağlı hipokalsemi, hipotermi, hiperkalemi ve hacim yüklenmesi gibi ciddi komplikasyon riskleri taşır. Ayrıca akciğerde mikroembolizasyon kaynaklı solunumsal sorunlar görülebilir. Bu nedenle MKT, komplikasyonların yakın takibiyle deneyimli bir ekip tarafından yönetilmelidir.
Massive blood transfusion (MBT) is a life-saving intervention traditionally defined as the transfusion of 10 units of red blood cell suspension within 24 hours or specific volumes within shorter periods. Its primary indication is hemodynamic instability due to acute blood loss, and it is of critical importance in cases such as trauma, aortic rupture, and surgical complications. Scoring systems like the ABC score are utilized to determine the patient's need for MBT. In MBT administration, it is recommended to provide red blood cells, plasma, and platelets in specific ratios (usually 1:1:1) to prevent coagulopathy. During the procedure, the use of short, large-bore catheters to ensure high flow rates and the warming of blood products to body temperature are essential. The process continues until target values, such as a mean arterial pressure of 60-65 mmHg and hemoglobin levels of 7-9 g/dL, are achieved. Massive transfusion carries risks of serious complications, including coagulopathy, hypocalcemia due to citrate toxicity, hypothermia, hyperkalemia, and volume overload. Additionally, respiratory issues stemming from microembolization in the lungs may occur. Therefore, MBT must be managed by an experienced team with close monitoring of potential complications.
Referanslar
Savage SA, Sumislawski JJ, Zarzaur BL, et al. The new metric to define large-volume hemorrhage: results of a prospective study of the critical administration threshold. J Trauma Acute Care Surg 2015; 78:224.
Meyer DE, Cotton BA, Fox EE, et al. A comparison of resuscitation intensity and critical administration threshold in predicting early mortality among bleeding patients: A multicenter validation in 680 major transfusion patients. J Trauma Acute Care Surg 2018; 85:691.)
Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al. Effect of Transfusion of Red Blood Cells With Longer vs Shorter Storage Duration on Elevated Blood Lactate Levels in Children With Severe Anemia: The TOTAL Randomized Clinical Trial. JAMA 2015; 314:2514.
Akkök ÇA, Seghatchian J. Pediatric red cell and platelet transfusions. Transfus Apher Sci. 2018 Jun;57(3):358-362.
Hess JR, Ramos PJ, Sen NE, Cruz-Cody VG, Tuott EE, Louzon MJ, Bulger EM, Arbabi S, Pagano MB, Metcalf RA. Quality management of a massive transfusion protocol. Transfusion. 2018 Feb;58(2):480-484.
Cantle PM, Cotton BA. Prediction of Massive Transfusion in Trauma. Crit Care Clin 2017;33(1):71-84. https://doi.org/10.1016/j.ccc.2016.08.002
Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63:805.
Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248:447.
Cotton BA, Au BK, Nunez TC, et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009; 66:41.
Shaz BH, Dente CJ, Nicholas J, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010; 50:493.
Inaba K, Lustenberger T, Rhee P, et al. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg 2010; 211:573.
de Biasi AR, Stansbury LG, Dutton RP, et al. Blood product use in trauma resuscitation: plasma deficit versus plasma ratio as predictors of mortality in trauma (CME). Transfusion 2011; 51:1925.
Perkins JG, Cap AP, Spinella PC, et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009; 66:S77.
Johansson PI, Stensballe J, Rosenberg I, et al. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion 2007; 47:593.
Shaz BH, Dente CJ, Nicholas J, MacLeod JB, Young AN, Easley K, Ling Q, Harris RS, Hillyer CD. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010;50(2):493-500. https://doi.org/10.1111/j.1537-2995.2009.02414.x. Epub 2009 Oct 5
Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB. The ratio of blood products transfused affects mortality in patients receiving massivetransfusions at a combat support hospital. J Trauma 2007;63(4):805-13.
Kornblith LZ, Howard BM, Cheung CK, et al. The whole is greater than the sum of its parts: hemostatic profiles of whole blood variants. J Trauma Acute Care Surg 2014; 77:818.
Hardy JF, De Moerloose P, Samama M, Groupe d'intérêt en Hémostase Périopératoire. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2004; 51:293.
Dzik WH, Kirkley SA. Citrate toxicity during massive blood transfusion. Transfus Med Rev 1988; 2:76.
Kermode JC, Zheng Q, Milner EP. Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 1999; 94:199.
Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008; 65:951.
Bruining HA, Boelhouwer RU, Ong GK. Unexpected hypopotassemia after multiple blood transfusions during an operation. Neth J Surg 1986; 38:48.
Smith HM, Farrow SJ, Ackerman JD, et al. Cardiac arrests associated with hyperkalemia during red blood cell transfusion: a case series. Anesth Analg 2008; 106:1062.
